Atlas Trials

Study of Sorafenib/Cetuximab in Head and Neck Cancer

Clinical trial NCT00815295 · COMPLETED

Trial details

NCT number
NCT00815295
Sponsor
Duke University
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Squamous Cell Cancer
Start date
2008-01-01
Primary completion
2013-07-01
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.